Program Morning Session

Chairs: Jérôme Cassayre, Syngenta and Thomas Heinz, Novartis

08.30 Welcome coffee, registration
08.55 Opening, welcome
Dr. Remo Gamboni, F. Hoffmann-La Roche
09.00 Dr. Andreas Marzinzik, Novartis Pharma AG
«Towards the goal of curing CML: discovery of ABL001 a novel allosteric inhibitor of BCR-ABL preventing disease relapse by dual targeting»
09.30 Dr. Kurt Püntener, F. Hoffmann-La Roche AG
«With asymmetric hydrogenation towards scalable, stereoselective syntheses of Aleglitazar and Bitopertin»
10.00 Dr. Ulla Létinois, DSM Nutritional Products AG
«Bio-based aromatic building blocks for vitamin E manufacture»
10.30 Coffee Break
11.00 Dr. Cheng-yi Chen, Janssen R&D, Cilag AG
«A Synthesis of 1H-Indazoles via a Cu(OAc)2-catalyzed N-N Bond Formation»
11.30 4x Short Talks à 8min
Dr. Kai-Uwe Schöning, BASF Schweiz AG
«Hindered amine polymer stabilizers – new discoveries in an established research area»
Dr. Alec Birkbeck, Firmenich SA
«From Leopold Ruzicka in 1935 until now: the story of (Z)-β-Santalol at Firmenich, towards an industrial synthesis»
Dr. Corinna Nimphius, Clariant International Ltd
«Glucamides – a new platform of sugar-based surfactants»
Dr. Wolfgang Haap, F. Hoffmann-La Roche AG
«Discovery of the cathepsin S inhibitor RG7625 for the treatment of autoimmune diseases»


Lunch and Poster Sessions

12.10 Lunch buffet
12.45 Poster sessions A (2nd and 3rd floor) and coffee 
13.15 Poster sessions B (2nd and 3rd floor) and coffee 


Program Afternoon Session

Chairs: Guido Koch, Novartis and Andrew Thomas, Roche

14.00 4x Short Talks à 8min
Dr. Myriem El Qacemi, Syngenta Crop Protection AG
«Enantioselective synthesis of insecticidal isothiazolines»
Dr. Fabrice Gallou, Novartis Pharma AG 
«Alternative solvents: from a compliance-driven activity to a trigger for innovation»
Dr. Johannes Schranck, Solvias AG
«Catalysis @ Solvias – from science to business»
Dr. Christian Lothschütz, Siegfried AG, Zofingen
«What can academia learn from industry?»
14.45 Dr. Stefan Abele, Actelion Pharmaceuticals Ltd.
«Pilot plant production of a P2Y12-antagonist containing (R)-3-Phosphonoalanine»
15.15 Dr. Christoph Taeschler, Lonza AG
«Process development aspects of alkylnitrites»
15.45 Coffee Break
16.15 Dr. Rolf Schaller, Dottikon Exclusive Synthesis AG
«Advanced process development into future»
16.45 Panel discussion with the lecturers
17.20 Award ceremony for the best poster presentation
Dr. Fabrice Gallou, Prof. Olivier Baudoin
17.30 Concluding Remarks: Dr. Alain De Mesmaeker, Syngenta / SCS President
Aperitif and Networking


Free admission. However, online registration until October 21 is mandatory.

Call for Abstracts for Poster Presentations
The call for abstract is closed.